NewsRoom Articles - Page 244 of 603

MondayAug 30, 2021 4:20 pm

420 with CNW — A Primer on Cannabis-Infused Beverages for Beginners

America’s state-legal cannabis industry has come a long way from the days of prohibition. More than a dozen states have now legalized some form of cannabis, and although it is still illegal at the federal level, cannabis sales are booming. The controversial plant has gotten so popular that the industry is raking in billions of dollars in sales less than a decade after state legal sales began. Concentrates have been the most popular cannabis products, but in the past year or so, cannabis-infused beverages have started giving concentrates a run for their money. Although cannabis beverages aren’t an entirely new…

MondayAug 30, 2021 4:20 am

420 with CNW — Why Similar Doses of Cannabis Edibles Could Have Vastly Different Effects

These days, anyone interested in trying cannabis has quite a wide range of product lines to choose from. Long gone are the days when the only cannabis product individuals could access was cannabis flower and poorly baked brownies, which was popularised by Alice B. Toklas in the 1960s. We’ve now got a plethora of different cannabis edible options, and anyone who have sampled different types of edibles know just how wildly different the experience can be. While the effects will generally be the same, regardless of the type of edible you consume, the onset of the effects and their longevity…

FridayAug 27, 2021 4:20 pm

420 with CNW — How CBG Differs from CBD Oil

The cannabis plant produces more than 100 compounds, among them CBD, which has been found to possess medical benefits. CBD and THC are the two main compounds produced by the cannabis plant. THC, or tetrahydrocannabinol, is what gives cannabis its psychoactive properties while CBD, or cannabidiol, makes up the plants’ healing properties. Other cannabinoids produced by the plant include CBN (cannabinol), CBC (cannabichromene) and CBG (cannabigerol). Below, we look at CBD and CBG as well as their reported benefits. What is CBG and CBD? As mentioned above, CBD is one of the most common extracts derived from the cannabis plant.…

FridayAug 27, 2021 10:47 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Presents CBN-Based Treatment for Glaucoma at H.C. Wainwright Ophthalmology Virtual Conference

The presentation highlighted the company’s INM-088 cannabinol topical eye drop to treat glaucoma InMed’s IntegraSyn is being used to help the company develop synthetic bioidentical rare cannabinoids in the lab, as most are only found in trace amounts in cannabis plants In addition to INM-088 for glaucoma, the company is currently working on CBN-based INM-755 to treat a rare genetic skin disorder called epidermolysis bullosa and is awaiting the answer to Phase II trial applications in various countries Dedicated to delivering new therapeutic alternatives as a treatment for conditions with a high unmet medical need, InMed Pharmaceuticals (NASDAQ: INM) is…

FridayAug 27, 2021 10:21 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Set to Announce Q2 2021 Results on August 30, 2021

Red White & Bloom Brands Inc. is set to release its Q2 2021 financial results on Monday, August 30, 2021 The announcement will also be followed by an update on the company’s asset purchases, accompanying notes along with management discussion and analysis Q1 2021 saw outstanding performance for the company, with the CEO announcing intentions to finalize its revised asset purchase of the Michigan investee The August 30 announcement will give an update to this and more investment decisions for Q2 2021 On July 27, 2021, Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) announced its 2021 1st quarter…

FridayAug 27, 2021 4:20 am

420 with CNW — Congressman Calls for Passing SAFE Banking Act Prior to Broader Law Reform

After months of telling the public that they were working on a federal cannabis bill, Senate Majority Leader Chuck Schumer, the Finance Chairman Ron Wyden, and Senator Cory Booker have unveiled their legislation for public comments. However, before Congress has the chance to look at and advance the Cannabis Administration and Opportunity Act, a Congressman would like lawmakers to pass a cannabis banking bill. Rep. Ed Perlmutter, who introduced a bill that would protect banking institutions which work with businesses in the cannabis space, has urged lawmakers to pass the legislation while lawmakers consider broader cannabis reform. Despite being allowed…

ThursdayAug 26, 2021 4:20 pm

420 with CNW — Feds Finance Research into Use of Hemp as Ecofriendly Insulation

The U.S. Department of Energy (“DOE”) is funding a project to develop hemp fiber insulation, which in comparison to traditional preparations, is said to be better for both public health as well as the environment. In addition to awarding almost $200,000 to facilitate research, the department granted Hempitecture’s COO Tommy Gibbons a yearly stipend of $90,000. The DOE is especially interested in the firm’s HempWool product, which is said to be a high-performing and extremely sustainable insulation material. The hemp-based product, which has a low carbon footprint and strong thermal resistance, is a nontoxic alternative to conventional insulation. In an…

ThursdayAug 26, 2021 4:20 am

420 with CNW — Why Similar CBD Products Often Have Different Prices

The difference in the prices of CBD products around the world has become more obvious in the past year. Since the coronavirus pandemic began, the demand for these products has risen significantly, and so has the production of cheap and expensive CBD products. Currently, the price difference between the least and most expensive products is about 4,715%. The gap is too large to be overlooked, given most CBD products are often used for various medical conditions, which is why these products should be evenly priced, thereby allowing everyone to have access to them. What is causing this huge difference in…

WednesdayAug 25, 2021 4:20 pm

420 with CNW — Gallup Poll: Nearly 50% of Adult Americans Have Used Marijuana

Cannabis is more popular among Americans than it has ever been. After decades of prohibition, the past few years have seen dozens of states pass cannabis legislation, and thanks to constant demand, the nascent state-legal cannabis industry has already generated billions of dollars in revenue. The controversial plant has been the most-used drug in the United States for years and according to a recently released poll by Gallup, nearly half of the adults in the country have consumed cannabis at one point in their lives. An estimated 49% of American adults have used cannabis at some point in their lives,…

WednesdayAug 25, 2021 11:12 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Pursues Commercial Production of Rare Cannabinoids at Pharmaceutical Levels

Canadian clinical-stage drug development company InMed Pharmaceuticals is working to achieve pharmaceutical approval of rare cannabinoids InMed Pharmaceutical has developed a trademarked platform called IntegraSyn that extracts five times the normally expected yields of cannabinoids from its plant sources IntegraSyn’s ability to increase yields may ultimately help InMed to achieve a profitable means of producing cannabinol (“CBN”) and other lesser-known cannabinoids at commercial scales To date, GW Pharma’s Epidiolex is the only cannabis-derived product to achieve FDA approval as a pharmaceutical, and the company’s multi-million-dollar revenues demonstrate the potential returns a pharmaceutical-level drug can achieve British Columbia, Canada-based InMed Pharmaceuticals…